Coronavirus vaccine candidate developed in Adelaide lab to start human trials


The first human trials of a potential coronavirus vaccine developed in Australia and based on a protein found in insect cells are about to begin in Adelaide.

Two doses of COVAX-19, or a placebo, will be injected into 40 healthy people between the ages of 18 and 65 at the Royal Adelaide Hospital’s clinical trial unit.

The vaccine candidate was developed by Adelaide-based company Vaxine, which has laboratories at Flinders University.

Another potential vaccine, developed in the US, made it to the human trials stage in Melbourne in late May.

But Vaxine research director Professor Nikolai Petrovsky said the human trials beginning in Adelaide today were the first for a vaccine developed in the southern hemisphere.

“I am very confident there will be successful vaccines against COVID-19,” he said.

“Hopefully ours will be one of those [but] ultimately the data will determine that. US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.